Sectors

  • Medical Technology
  • Service & Technology

Research Coverage

  • Accuray Incorporated (ARAY)
  • Augmedix Inc. (AUGX)
  • Butterfly Network, Inc. (BFLY)
  • Establishment Labs Holdings, Inc. (ESTA)
  • Hyperfine, Inc. (HYPR)
  • Paragon 28, Inc. (FNA)
  • PROCEPT BioRobotics Corporation (PRCT)
  • Stereotaxis, Inc. (STXS)
  • ViewRay, Inc. (VRAY)

Biography 

Neil Chatterji is a Senior Equity Research Analyst in the Healthcare Research Group with B. Riley Securities responsible for coverage of Medical Technology and Digital Health. He has almost a decade of experience in equity research with a focus in healthcare. He joined the healthcare equity research team in 2022 to focus on coverage of emerging SMiD-cap medical device and digital health companies with differentiated technologies.

Prior to B. Riley, he mostly recently was at Cowen as a Vice President in research covering Medical Devices, covering all cap companies focused on a range of technologies including for cardiology, orthopedics, and robotics / digital health. He has also held research positions at BMO (MedTech), Sidoti (Digital Health / HCIT), and Craig-Hallum, and in investor relations at AbbVie. Prior to his roles in equity research, he worked in healthcare strategy for providers and payors and in hospital administration.

Neil is a member of the Leadership Board for the Applied Security Analysis Program at the University of Madison-Wisconsin, and a philanthropic advocate for the Colorectal Cancer Alliance. He received his MBA from the University of Madison-Wisconsin, participating in the esteemed Applied Security Analysis Program, an MHA in healthcare management from the George Washington University, and a B.S. in business administration in finance and economics from the Ohio State University.

B. Riley Securities provides a full suite of investment banking, corporate finance, advisory, research, and sales and trading services. Investment banking services include initial, secondary and follow-on offerings, institutional private placements, merger and acquisition (M&A) advisory, SPACs, corporate restructuring and recapitalization. B. Riley is nationally recognized and highly ranked for its proprietary small-cap equity research. B. Riley Securities formerly operated as B. Riley FBR following the merger of B. Riley & Co. and FBR & Co.